Ameritas Investment Company’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$495K Buy
11,398
+5,004
+78% +$221K 0.02% 420
2021
Q2
$656K Buy
6,394
+1,043
+19% +$43.9K 0.03% 359
2021
Q1
$207K Sell
5,351
-4,027
-43% -$152K 0.02% 573
2020
Q4
$337K Buy
9,378
+6
+0.1% +$216 0.07% 286
2020
Q3
$329K Hold
9,372
0.1% 217
2020
Q2
$329K Sell
9,372
-5,071
-35% -$183K 0.09% 223
2020
Q1
$464K Buy
14,443
+1,512
+12% +$59.1K 0.07% 200
2019
Q4
$585K Buy
12,931
+9,471
+274% +$396K 0.12% 162
2019
Q3
$141K Buy
+3,460
New +$147K 0.03% 396
2019
Q2
Sell
-5,057
Closed -$194K 307
2019
Q1
$194K Buy
+5,057
New +$193K 0.04% 306

Other funds holding BSX

Ameritas Investment Company's BSX Position: Q3 2021 in Review

Ameritas Investment Company increased its Boston Scientific (BSX) stake by 78% in Q3 2021, buying an estimated $221K and bringing the position to 11,398 shares worth $495K. The position accounts for 0.02% of the portfolio, ranked #420.

Ameritas Investment Company first reported a position in BSX in Q1 2019 and has held it in 10 quarters since. The position peaked at $656K in Q2 2021. 878 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

  • Ameritas Investment Company held 11,398 shares of Boston Scientific worth $495K as of Q3 2021.
  • Ameritas Investment Company bought 5,004 Boston Scientific shares in Q3 2021, an estimated $221K.
  • Boston Scientific made up 0.02% of Ameritas Investment Company's portfolio in Q3 2021, its #420 holding.
  • Ameritas Investment Company first reported a position in Boston Scientific in Q1 2019 and has held it in 10 quarters since.
  • Ameritas Investment Company's Boston Scientific position peaked at $656K in Q2 2021.
  • 878 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.